<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3993628&amp;fmt=gif">
Skip to the main content.

Neural Connections Blog

MD Biosciences insights discussing preclinical research in Pain and Neurodegenerative Conditions

neurodegenerative

Advancing Parkinson’s Research: Insights from Diverse Disease Models

Parkinson’s Disease (PD) is a progressive neurodegenerative movement disorder that affects millions of people worldwide. PD is characterized by the...

Read More
MOG-induced EAE preclinical CRO for neurodegenerative and CNS

Do clinical scores tell us all we need to know?

Multiple sclerosis is a disease in which the immune system attacks the myelin sheath that covers nerve fibers. People suffering from this autoimmune...

Read More

Monitoring pain in EAE animals experiencing paralysis

Many neurodegenerative diseases such as Multiple Sclerosis, ALS, and Rhett Syndrome involve paralysis. When developing new treatments, it is...

Read More
Multiple-Sclerosis-Myelin-EAE-Batch-Release-Testing-GLP-Copaxone_Generics.jpg

Glatiramer Acetate (Copaxone® Generics) and Batch Release Testing in MS/EAE at MD Biosciences

MDB Gains OECD-GLP certification for In Vivo Glatiramer Acetate Batch Release Testing Services

Read More
animal model of parkinsons 6-OHDA

Behavior tests used with the 6-OHDA model of PD, and what they tell us.

6-OHDA lesioned rats exhibit a number of motor behavioral and non-motor impairments which have been examined with a variety of tests, summarized...

Read More